Introduction: Development of bacterial resistance to the available antibiotics and increasing popularity of traditional medicine has led researchers to investigate the antibacterial compounds in plants. In this context, curcumin has been shown to have a range of beneficial properties, like antimicrobial and anti-inflammatory properties, which might be favorable for the treatment of inflammatory diseases like periodontitis.
INTRODUCTION
Periodontal disease is a chronic inflammatory disease of the supporting tissues of the teeth, triggered by the host's immune response to microbial plaque. This results in the
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progressive loss of tooth-supporting tissues, which ultimately can lead to premature tooth loss. Gingivitis and periodontitis, which are the two most common forms of periodontal diseases, are caused by the bacteria present in the plaque biofilm. This biofilm community is initially formed through bacterial interactions with the tooth and then through physical and physiologic interactions among different species within the microbial mass. Furthermore, the bacteria found in the plaque biofilm are strongly influenced by external environmental factors that may be host mediated.
Various microorganisms are known to be asso ciated with periodontitis, such as Porphyromonas gin gi valis, Prevotella intermedia, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, etc.
2 However, elevated proportions of some predominant subgingival microbial species like P. gingivalis and A. actinomycetemcomitans, have been associated with destructive periodontal disease activity. Thus, an essential component of periodontal therapy is to suppress the pathogenic microflora of the pocket, which may be accomplished by either non surgical or surgical means. 4 Nonsurgical approach in the form of scaling and root planning has proven to be successful in immediately reducing the microbial load but it sometimes fails to eliminate the bacteria in inaccessible areas, leading to recurrence of disease. Hence, the use of antimicrobial agents, both systemic and topical, has eventually increased because of the realization that periodontal disease is not only an overgrowth of bacteria, but also a shift in bacterial species.
5
Systemic administration of antimicrobial drugs has been useful in treating periodontal pockets. However, it involves consumption of a relatively high dose with repeated intake over a prolonged period of time to achieve the required inhibitory concentrations in the sulcular fluid. This increases the possibility of development of resistance, alteration of commensal flora and increased potential for adverse effects, such as allergic/anaphylactic reactions, gastric disturbances, superinfection, nausea, vomiting, etc. Local administration of these antimicrobial drugs provides answers to problems of systemic administration with no systemic side-effects. At the same time, this approach again relies on the ability to control and prolong the release rate of the therapeutic agent from the device.
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Owing to the clinical drawbacks of synthetic agents (both systemic and topical), there was an imminent need of an alternative medicine that could provide a product already enmeshed within the traditional Indian setup and is also safe and economical.
In this context, Curcuma longa, a medicinal plant that botanically is related to Zingiberaceae family, 7 was the need of the hour. Curcuma longa, commonly known as 'turmeric', is widely used as a spice and coloring agent, and is well known for its medicinal properties.
8
Components of turmeric are called curcuminoids, which mainly include curcumin (diferuloylmethane), demethoxycurcumin and bisdemethoxycurcumin. 9 Among the three components, curcumin is the most important fraction which is responsible for the biological activities of turmeric. 10 It has been shown that curcumin has a wide spectrum of biological actions, such as antibac terial, anti-inflammatory, antioxidant, antidiabetic, anti cancer, antiallergic and many more.
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Recent research has also proven that periodontal breakdown is caused by interaction of bacteria with the host immune response with the help inflammatory mediators and free radicals. Therefore, the antibacterial, anti-inflammatory and antioxidant properties of curcumin are desirable assets which might validate its use in the treatment of periodontitis.
A. actinomycetemcomitans is a Gram-negative capnophilic bacterium. Due to the tissue invasion property of this bacterium, it is regarded as a patho gen associated with one forms of periodontitis-localized aggressive periodontitis.
12 This bacterium is also associated with systemic infections that can result in endocarditis, meningitis and brain abscesses.
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Therefore, this study was conducted to evaluate the antibacterial role of curcumin against one of the most tissue invasive periodontal pathogen-A. actinomycetemcomitans.
MATERIALS AND METHODS
The test agent used in this study was 5% curcumin (Sami Labs Limited, Peenya, Bengaluru, Karnataka). The rhizomes of Curcuma longa were extracted using acetone as a solvent and the extract was then dissolved with isopropyl alcohol to achieve a final extract ratio of 50:1 to 60:1.
The test organism was A. actinomy cetemcomitans (ATCC 29523).
Bacterial Strains and Maintenance Procedure
The needed bacterial strain from the stock were revived by plating on blood agar medium. After overnight incubation at 37°C, those were transferred to sterile BHI broth and once again incubated overnight. The growth concentration was adjusted to 5 × 10 5 organisms/ml by using 0.5 McFarland's turbidity standard. After the incubation, the MIC values were determined by visual inspection of the tubes. In each series of tubes, the last tube with clear supernatant was considered to be without any growth and taken as MIC value. Turbidity in the MIC tube indicated growth of the bacteria implying that the bacteria are resistant to curcumin (Fig. 1) .
Determination of Minimum

RESULTS
The serial dilutions of curcumin extract with turbidity response of A. actinomycetemcomitans is summarized as follows (Table 1) .
Thus, curcumin has the ability to exert antibacterial activity against A. actinomycetemcomitans at a minimum inhibitory concentration of 0.2 µg/ml. 
DISCUSSION
Despite the availability of a wide range of antimicrobial agents for clinical use, development of new antimicrobial agents remains important and many studies have been aiming at the discovery and development of new antimicrobial agents.
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The combination of microorganisms and inflammatory response are the cause of many diseases, including perio dontitis, for which compounds having a dual antiinflammatory and antimicrobial activity may be desirable therapeutic agents. 16 Globally, plant extracts are employed for their antibacterial, antifungal and antiviral activities. It is known that more than 400,000 species of tropical flowering plants have medicinal properties and this has made traditional medicine cheaper than modern medicine.
17
In this study, it was thus suggested that curcumin has the ability to exert antibacterial activity against one of the most tissue invasive periodontal pathogen-A. actinomycetemcomitans, at a minimum inhibitory concen tration of 0.2 µg/ml.
Thus, the results of this study corroborate with the findings of study by Mandroli et al, which was done to evaluate the ability of curcumin to exert anti bacterial activity against common endodontic bacteria like Strepto coccus mutans, Actinomyces viscosus, Lactobacillus casei, P. gingivalis, Prevotella intermedia and Enterococcus faecalis. 18 It was, hence, suggested that curcumin has the ability to kill several Gram-positive and Gram-negative bacteria.
A study by Rai et al suggested that curcumin may inhibit bacterial cell proliferation by inhibiting the assembly dynamics of FtsZ (a bacterial protofilament), which polymerizes to form a Z-ring at the midcell that orchesterates bacterial cell division. The assembly and stability of FtsZ protofilaments have been shown to play critical roles in bacterial cytokinesis. Thus, FtsZ may be considered as an important antibacterial drug target. It was suggested that curcumin strongly inhibited the formation of the cytokinetic Z-ring, which would prove lethal to bacteria, thus, accounting for curcumin's antibacterial activity.
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Another reason which might be suggested for the antibacterial potential of curcumin is that curcumin is a polyphenolic compound, also having substantial antibiofilm activity. 20 It inhibits the production of biofilm and disperses the biofilm made by many microorganisms. Owing to the plaque biofilm acting as the main etiological factor in the periodontal diseases, curcumin's antibiofilm activity would also account for its antibacterial activity against periodontal pathogens. Apart from the antibacterial property, curcumin is a molecule known to demonstrate antifungal activity 21 and antiviral activity as well.
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Further, curcumin has long been touted as a powerful anti-inflammatory and immunomodulatory agent.
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Curcumin has been shown to regulate numerous transcription factors, cytokines, protein kinases, adhesion molecules, redox status and enzymes that have been linked to inflammation.
The anti-inflammatory activity of curcumin was first reported in 1971. 24 It reduces inflammation by effectively inhibiting transcriptional and translational expression of proinflammatory cytokines like IL-6 and TNF-a. Curcumin also demonstrated dose-dependent attenuation of NF-kb activation in the gingival tissue of rats suffering from experimental periodontal disease. It, further, reduced the inflammatory infiltrate, increased the collagen content, and increased fibroblastic cell numbers in gingival tissues.
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Because of the increasing evidence that the pathogenesis of type 2 diabetes mellitus (T2DM) and obesity is connected to inflammation, curcumin has emerged as a potential drug of interest for diabetic and obesity pharmacology.
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Of all the possible clinical applications of curcumin, none has garnered more interest and investment of research resources and manpower than the potential use of curcumin as a cancer chemopreventive and chemo therapeutic agent. 27 Curcuminoids possess anticarcinogenic property due to their oxygen radical-scavenging property. 28 This interest and this voluminous amount of investigations continue unabated. Despite extensive research and development, poor oral bioavailability of curcumin remains one of the major concerns for its use as a therapeutic agent. This poor oral bioavailability of curcumin can be attributed to its poor absorption, high rate of metabolism in the intestines and rapid systemic elimination from the body. Thus, attempts have been made to improve curcumin's bioavailability by use of adjuvants that can block the metabolic pathway of curcumin. This has been achieved through encapsulation in liposomes, biodegradable microspheres, cyclodextrin, and hydrogels. Also, various controlled delivery forms, such as polymeric micro/nanospheres, liposomes, micelles, parenteral emulsion, and prodrugs have been investigated to increase its solubility. 
CONCLUSION
Due to multiple therapeutic properties and pleiotropic roles, curcumin can be considered a safe, nontoxic and effective alternative for the treatment of inflammatory condi tions like periodontitis. However, further research is warranted to determine the optimal dosage, bioavailabilty and bioefficacy of curcumin-based drugs. As the number of research studies on therapeutic effects of curcumin keeps on increasing, it is evident that curcumin truly holds a promising future in therapeutic applications including dentistry.
